Results 141 to 150 of about 2,626 (203)

New Topical and Systemic Treatments for Atopic Dermatitis. [PDF]

Clin Exp Allergy
Mirali S, Drucker AM.
europepmc   +1 more source

Effectiveness of Switching From Upadacitinib to Tralokinumab in Patients With Moderate-to-Severe Atopic Dermatitis: A Real-World Clinical Practice. [PDF]

Ann Dermatol
Hagino T, Saeki H, Fujimoto E, Kanda N.
europepmc   +1 more source

Erythrodermic atopic dermatitis responding to tralokinumab after dupilumab failure

Indian Journal of Dermatology, Venereology and Leprology
Aida, Lara-Moya, Vicente, Exposito-Serrano, Patricia, Garbayo-Salmons, Mireia Sabat, Santandreu   +3 more
openaire   +2 more sources

Bridging the cost divide: comparing veterinary and human dermatologic drug pricing in the US. [PDF]

Proc (Bayl Univ Med Cent)
Dowdle TS, Schmidt M, Remmert N, Munoz A.   +3 more
europepmc   +1 more source

Anticorpi monoclonali per il trattamento della dermatite atopica: Tralokinumab

In questa tesi tratteremo la dermatite atopica che è una malattia infiammatoria cronica della pelle che si presenta con prurito e diverse manifestazioni cutanee tra cui eritema, papule-vescicole e secchezza cutanea; tale malattia viene ad essere trattata i diversi modi ed in particolare andremo a vedere il trattamento con un nuovo farmaco di recente ...
openaire   +1 more source

<i>In vitro</i> potency and pharmacokinetics of APG777, a novel anti-IL-13 mAb. [PDF]

J Allergy Clin Immunol Glob
Zhu E, Prentice H, Oh J, Shaheen H, Gandhi NA, Wickman G, Dabora R, Dambkowski CL, Dillinger L.   +8 more
europepmc   +1 more source

Lebrikizumab for the Treatment of Moderate to Severe Atopic Eczema: Real-World Experience from a Tertiary Centre. [PDF]

Dermatol Ther (Heidelb)
Abraheem A, Sebastian N, Kreeshan FC, Clayton TH, Hunter HJA, Warren RB.   +5 more
europepmc   +1 more source

Long-Term Efficacy and Potential Predictors of Tralokinumab Dose Optimization in Elderly Patients: A Multicentre Study. [PDF]

Dermatol Ther (Heidelb)
Melgosa Ramos FJ, Alarcón SS, Motilla JMS, Mercader P.   +3 more
europepmc   +1 more source

Beyond the blockade: unmet needs in systemic targeted atopic dermatitis therapy. [PDF]

Front Immunol
Zhang L, Peng G, Wang M, Niyonsaba F, Gao X.   +4 more
europepmc   +1 more source